株式会社極東書店トップ ＞ 商品一覧 ＞ Immunogenicity of Biopharmaceuticals. 2008 ed.
商品詳細
Immunogenicity of Biopharmaceuticals. 2008 ed.
・ISBN 978-0-387-75840-4 hard EUR 149.99
￥40,091.- (税込) ※（※）価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
| 著者・編者 | Weert, Marco / Moller, Eva Horn (eds.), |
|---|---|
| シリーズ | (Biotechnology: Pharmaceutical Aspects) |
| 出版社 | (Springer-Verlag New York Inc., US) |
| 出版年月 | 2008 |
| ページ数 | 266 pp. |
| 言語 | ENG |
| ニュース番号 | ＜A05-43875＞ |
解説
A particular issue for biopharmaceuticals that has not been addressed comprehensively in any book, is the potential of an immune response to the biopharmaceutical product. That is, the human body marks the drug as a foreign body, and develops antibodies against the drug. These antibodies may be relatively harmless, but may also cross-react with the endogenous compound, causing autoimmunogenicity. Recent adverse experiences in Europe with Janssen-Ortho's blockbuster product Eprex has increased the attention towards potential immunogenicity of biopharmaceuticals, above all from the regulatory agencies.
This book is intended to give a broad overview of the current state-of-the-art regarding the immune response to biopharmaceuticals. The chapters range from an overview of the immune system and factors that may trigger the immune system, via detection of antibodies and clinical implications, to various case examples and the regulatory view on immunogenicity.